1 Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: a phase II, a randomized, comparative trial in Kazakhstan.

2 Immunological insights on influenza infection and vaccination during immune checkpoint blockade in cancer patients.

3 A recombinant avian paramyxovirus serotype 3 expressing the hemagglutinin protein protects chickens against H5N1 highly pathogenic avian influenza virus challenge.

4 Impact of influenza vaccine-modified infectivity on attack rate, case fatality ratio and mortality.

5 influenza virus-mediated membrane fusion: determinants of hemagglutinin fusogenic activity and experimental approaches for assessing virus fusion

6 experimental approaches to study genome packaging of influenza a viruses

7 modified vaccinia virus ankara (mva) as production platform for vaccines against influenza and other viral respiratory diseases

8 new kids on the block: rna-based influenza virus vaccines

9 comparison of mortality associated with respiratory viral infections between december 2019 and march 2020 with that of the previous year in southeastern france

10 genetic variation and drug resistance mutation of influenza virus during 2013-2014 in beijing, china: a report of 37 cases

11 large-scale analysis of b-cell epitopes on influenza virus hemagglutinin - implications for cross-reactivity of neutralizing antibodies

12 ns segment of a 1918 influenza a virus-descendent enhances replication of h1n1pdm09 and virus-induced cellular immune response in mammalian and avian systems

13 assessment of the rnasound rna sampling card for the preservation of influenza virus rna

14 un-“escrt”-ed budding

15 san wu huangqin decoction, a chinese herbal formula, inhibits influenza a/pr/8/34 (h1n1) virus infection in vitro and in vivo

16 carbonate apatite nanoparticles act as potent vaccine adjuvant delivery vehicles by enhancing cytokine production induced by encapsulated cytosine-phosphate-guanine oligodeoxynucleotides

17 antiviral decoction of isatidis radix (板藍根 bǎn lán gēn) inhibited influenza virus adsorption on mdck cells by cytoprotective activity

18 therapeutic impact of human serum albumin-thioredoxin fusion protein on influenza virus-induced lung injury mice

19 influenza virus and endothelial cells: a species specific relationship

20 Triple combination therapy of favipiravir plus two monoclonal antibodies eradicates influenza virus from nude mice

21 The added value of online user-generated content in traditional methods for influenza surveillance - Scientific Reports

22 The added value of online user-generated content in traditional methods for influenza surveillance - Scientific Reports

23 Antiviral resistance markers in influenza virus sequences in Mexico, 2000–2017

24 Antiviral resistance markers in influenza virus sequences in Mexico, 2000–2017

25 Human parainfluenza virus-associated respiratory tract infection among children and genetic analysis of HPIV-3 strains in Beijing, China.

26 Editorial: Epidemiology of Avian Influenza Viruses.

27 Polygalasaponin F treats mice with pneumonia induced by influenza virus.

28 A Perfect Storm: Increased Colonization and Failure of Vaccination Leads to Severe Secondary Bacterial Infection in Influenza Virus-Infected Obese Mice

29 Activity of isatine-sulfadimidine derivatives against 2009 pandemic H1N1 influenza virus in cell culture.

30 Protective immunity against influenza virus challenge by norovirus P particle-M2e and HA2-AtCYN vaccines in chickens.

31 Intercontinental spread of Asian-origin H7 avian influenza viruses by captive bird trade in 1990's.

32 The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo.

33 New molecular evolutionary characteristics of H9N2 avian influenza virus in Guangdong Province, China.

34 Antigenic and genetic characterization of influenza viruses isolated in Mozambique during the 2015 season.

35 Risk factors for H5 avian influenza virus prevalence on urban live bird markets in Jakarta, Indonesia-Evaluation of long-term environmental surveillance data.

36 Experimental Approaches to Identify Host Factors Important for Influenza Virus.

37 Zoonosis Update on H9N2 Avian Influenza Virus

38 Hormonal Regulation of Physiology, Innate Immunity and Antibody Response to H1N1 Influenza Virus Infection During Pregnancy

39 Structure and Hierarchy of Influenza Virus Models Revealed by Reaction Network Analysis.

40 RNA Extraction from Equine Samples for Equine Influenza Virus.

41 Predicting the short-term success of human influenza virus variants with machine learning.

42 The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro

43 ECOLOGICAL DETERMINANTS OF AVIAN INFLUENZA VIRUS, WEST NILE VIRUS, AND AVIAN PARAMYXOVIRUS INFECTION AND ANTIBODY STATUS IN BLUE-WINGED TEAL (ANAS DISCORS) IN THE CANADIAN PRAIRIES.

44 Cloning, expression, and purification of the recombinant hemagglutinin of human influenza virus H1N1 in the eukaryotic insect cells using baculovirus vector

45 Delayed Clearance of Viral Load and Marked Cytokine Activation in Severe Cases of Pandemic H1N1 2009 Influenza Virus Infection

46 Protective Efficacy of Seasonal Influenza Vaccination against Seasonal and Pandemic Influenza Virus Infection during 2009 in Hong Kong

47 Pathogenesis of Severe Acute Respiratory Infections in the Developing World: Respiratory Syncytial Virus and Parainfluenza Viruses

48 Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine

49 Pathogenesis of Respiratory Infections Due to Influenza Virus: Implications for Developing Countries

50 Incidence of Influenza Virus Infections in Children in Hong Kong in a 3-Year Randomized Placebo-Controlled Vaccine Study, 2009–2012

51 Pathogenesis of Respiratory Infections Due to Influenza Virus: Implications for Developing Countries

52 Effects of Oseltamivir Treatment on Duration of Clinical Illness and Viral Shedding and Household Transmission of Influenza Virus

53 Clinical and epidemiological characterization of influenza virus infections in children with severe acute respiratory infection in Maputo, Mozambique: Results from the implementation of sentinel surveillance, 2014 – 2016

54 Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections

55 Clinical and epidemiological characterization of influenza virus infections in children with severe acute respiratory infection in Maputo, Mozambique: Results from the implementation of sentinel surveillance, 2014 - 2016

56 An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines

57 Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population

58 expression of concern on “modes of antiviral action of chemical portions and constituents from woad root extract against influenza virus a fm1”

59 dryocrassin abba, a novel active substance for use against amantadine-resistance h5n1 avian influenza virus

60 epidemiology and clinical presentation of the four human parainfluenza virus types

61 paivs: prediction of avian influenza virus subtype

62 disulfide isomerase erp57 improves the stability and immunogenicity of h3n2 influenza virus hemagglutinin

63 the impact of climate and antigenic evolution on seasonal influenza virus epidemics in australia

64 intranasal vaccination with an engineered influenza virus expressing the receptor binding subdomain of botulinum neurotoxin provides protective immunity against botulism and influenza

65 contribution of the purinergic receptor p2x7 to development of lung immunopathology during influenza virus infection

66 intranasal immunization with influenza virus-like particles containing membrane-anchored cholera toxin b or ricin toxin b enhances adaptive immune responses and protection against an antigenically distinct virus

67 presença do vírus da gripe no sangue e órgãos de animais inoculados por via intracardíaca presence of the influenza virus in the blood and organs of animals inoculated by intracardiac route

68 dendritic cells in innate and adaptive immune responses against influenza virus

69 virus shedding in co-infections of low pathogenic avian influenza virus ( h6n2 ) and lentogenic newcastle disease virus (la sota) in numida meleagris

70 a hypothesis: supplementation with mushroom-derived active compound modulates immunity and increases survival in response to influenza virus (h1n1) infection

71 examination of pathological process pecularities caused by a/duck/altai/469/14 h5n1 isolate of avian influenza virus in chickens

72 chemical genomics identifies the perk-mediated unfolded protein stress response as a cellular target for influenza virus inhibition

73 influenza virus segment composition influences viral stability in the environment

74 estudo sorológico sobre a cepa a/new jersey/8/76 em grupos populacionais brasileiros: nota prévia serologic study of the a/new jersey/8/76 influenza virus in brazilian population groups: communication

75 comparison of porcine airway and intestinal epithelial cell lines for the susceptibility and expression of pattern recognition receptors upon influenza virus infection

76 geldanamycin reduces acute respiratory distress syndrome and promotes the survival of mice infected with the highly virulent h5n1 influenza virus

77 erratum for gui et al., electron tomography imaging of surface glycoproteins on human parainfluenza virus 3: association of receptor binding and fusion proteins before receptor engagement

78 initial influenza virus replication can be limited in allergic asthma through rapid induction of type iii interferons in respiratory epithelium

79 dual acting neuraminidase inhibitors open new opportunities to disrupt the lethal synergism between streptococcus pneumoniae and influenza virus

80 mx bio adjuvant for enhancing immune responses against influenza virus

81 a review: evaluating the dynamics of influenza viruses replication and host cell- virus interactions

82 current approaches for diagnosis of influenza virus infections in humans

83 cytokine profiles of severe influenza virus-related complications in children

84 characterisation and identification of avian influenza virus (ai)

85 rare sox2+ airway progenitor cells generate krt5+ cells that repopulate damaged alveolar parenchyma following influenza virus infection

86 generation of adaptive immune responses following influenza virus challenge is not compromised by pre-treatment with the tlr-2 agonist pam2cys

87 characterization and epidemiology of influenza viruses in patients seeking treatment for influenza-like illnesses in rural bangladesh

88 genetical evaluation of resistance to amantadine in h9n2 avian influenza virus in iran between 1998 to 2009

89 mucosa-associated lymphoid tissue lymphoma translocation protein 1 positively modulates matrix metalloproteinase-9 production in alveolar macrophages upon toll-like receptor 7 signaling and influenza virus infection

90 characterisation of enzymatic activities of h5n1 influenza virus

91 the application of nhej-crispr/cas9 and cre-lox system in the generation of bivalent duck enteritis virus vaccine against avian influenza virus

92 the effect of virgin coconut oil on lymphocyte and cd4 in chicken vaccinated against avian influenza virus

93 Cutting edge: stealth influenza virus replication precedes the initiation of adaptive immunity

94 Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants

95 Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets

96 Monitoring of neuraminidase inhibitor resistance among clinical influenza virus isolates in Japan during the 2003-2006 influenza seasons

97 Development of a guinea pig colony free of complement-fixing antibodies to parainfluenza virus

98 Cutting Edge: Stealth Influenza Virus Replication Precedes the Initiation of Adaptive Immunity

99 The Dynamic Relationship Between Clinical Symptomatology and Viral Shedding in Naturally Acquired Seasonal and Pandemic Influenza Virus Infections

100 Combined Inhibition of Influenza Virus Reproduction in Cell Culture using Interferon and Amantadine - Nature

101 Combined Inhibition of Influenza Virus Reproduction in Cell Culture using Interferon and Amantadine - Nature

Keyword Connections

Journals

Research Groups

Bibliographies